Xenetic Biosciences GAAP EPS of -0.28, revenue of 614.1M
| GYRE Stock | 11.75 1.16 8.99% |
About 62% of Gyre Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Gyre Therapeutics stock suggests that many investors are alarmed at this time. The current market sentiment, together with Gyre Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Gyre Therapeutics stock news signals to limit their universe of possible portfolio assets.
Gyre |
Xenetic Biosciences reports Q3 2024 financial results with GAAP EPS of -0.28 and revenue of 614.1M.
Read at seekingalpha.com
 |
Gyre Therapeutics Fundamental Analysis
We analyze Gyre Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gyre Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gyre Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Gyre Therapeutics is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Gyre Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gyre Therapeutics stock to make a market-neutral strategy. Peer analysis of Gyre Therapeutics could also be used in its relative valuation, which is a method of valuing Gyre Therapeutics by comparing valuation metrics with similar companies.
Peers
Gyre Therapeutics Related Equities
| PNR | Pentair PLC | 1.80 | ||||
| BJRI | BJs Restaurants | 1.48 | ||||
| YUM | Yum Brands | 0.52 | ||||
| SHAK | Shake Shack | 0.13 | ||||
| WEN | Wendys | 1.10 | ||||
| ALK | Alaska Air | 1.58 | ||||
| PVARF | Porvair Plc | 2.22 |
Complementary Tools for Gyre Stock analysis
When running Gyre Therapeutics' price analysis, check to measure Gyre Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gyre Therapeutics is operating at the current time. Most of Gyre Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gyre Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gyre Therapeutics' price. Additionally, you may evaluate how the addition of Gyre Therapeutics to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |